» Articles » PMID: 38786020

SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment

Overview
Journal Cells
Publisher MDPI
Date 2024 May 24
PMID 38786020
Authors
Affiliations
Soon will be listed here.
Abstract

A heterogenous population of inflammatory elements, other immune and nonimmune cells and cancer-associated fibroblasts (CAFs) are evident in solid malignancies where they coexist with the growing tumor mass. In highly desmoplastic malignancies, CAFs are the prominent mesenchymal cell type in the tumor microenvironment (TME), where their presence and abundance signal a poor prognosis. CAFs play a major role in the progression of various cancers by remodeling the supporting stroma into a dense, fibrotic matrix while secreting factors that promote the maintenance of cancer stem-like characteristics, tumor cell survival, aggressive growth and metastasis and reduced sensitivity to chemotherapeutics. Tumors with high stromal fibrotic signatures are more likely to be associated with drug resistance and eventual relapse. Identifying the molecular underpinnings for such multidirectional crosstalk among the various normal and neoplastic cell types in the TME may provide new targets and novel opportunities for therapeutic intervention. This review highlights recent concepts regarding the complexity of CAF biology in cholangiocarcinoma, a highly desmoplastic cancer. The discussion focuses on CAF heterogeneity, functionality in drug resistance, contributions to a progressively fibrotic tumor stroma, the involved signaling pathways and the participating genes.

Citing Articles

CircPRMT5, a Potential Salivary Biomarker, Facilitates the Progression of Head and Neck Squamous Cell Carcinoma via the IGF2BP3-SERPINE1 Pathway.

Jiang S, Ou L, Wang Y, Su K, Chen Z, He L Int J Nanomedicine. 2025; 20:1597-1613.

PMID: 39931528 PMC: 11807777. DOI: 10.2147/IJN.S502400.


New Relevant Evidence in Cholangiocarcinoma Biology and Characterization.

Porro N, Spinola-Lasso E, Pastore M, Caligiuri A, Di Tommaso L, Marra F Cancers (Basel). 2025; 16(24.

PMID: 39766138 PMC: 11674836. DOI: 10.3390/cancers16244239.


Identification of adipocyte infiltration-related gene subtypes for predicting colorectal cancer prognosis and responses of immunotherapy/chemotherapy.

Fu D, Zhang T, Liu J, Chang B, Zhang Q, Tan Y Heliyon. 2024; 10(13):e33616.

PMID: 39050460 PMC: 11266998. DOI: 10.1016/j.heliyon.2024.e33616.

References
1.
Seebacher T, Manske M, Zoller J, Crabb J, BADE E . The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks. Exp Cell Res. 1992; 203(2):504-7. DOI: 10.1016/0014-4827(92)90029-8. View

2.
Mignatti P, Rifkin D . Nonenzymatic interactions between proteinases and the cell surface: novel roles in normal and malignant cell physiology. Adv Cancer Res. 1999; 78:103-57. DOI: 10.1016/s0065-230x(08)61024-6. View

3.
Perez C, Ott J, Mays D, Pietenpol J . p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Oncogene. 2007; 26(52):7363-70. DOI: 10.1038/sj.onc.1210561. View

4.
Lawrence D, Palaniappan S, Stefansson S, Olson S, SHORE J, Ginsburg D . Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis. J Biol Chem. 1997; 272(12):7676-80. DOI: 10.1074/jbc.272.12.7676. View

5.
Al-Fakhri N, Chavakis T, Schmidt-Woll T, Huang B, Cherian S, Bobryshev Y . Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties. Biol Chem. 2003; 384(3):423-35. DOI: 10.1515/BC.2003.048. View